Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-23-042643
Filing Date
2023-12-22
Accepted
2023-12-22 16:29:18
Documents
18
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zlab-20221231.htm   iXBRL 10-K/A 153624
2 EX-31.3 a313certificationofchiefex.htm EX-31.3 4346
3 EX-31.4 a314certificationofchieffi.htm EX-31.4 4368
4 EX-99.1 a991disclosureregardingfor.htm EX-99.1 6202
9 zlab-20221231_g1.jpg GRAPHIC 14140
  Complete submission text file 0001628280-23-042643.txt   466416

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20221231.xsd EX-101.SCH 2900
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20221231_def.xml EX-101.DEF 22643
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20221231_lab.xml EX-101.LAB 45516
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20221231_pre.xml EX-101.PRE 26207
12 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20221231_htm.xml XML 6822
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38205 | Film No.: 231510213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)